These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23884058)

  • 21. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital.
    Scheft H; Fontenette DC
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.
    Schaefer M; Capuron L; Friebe A; Diez-Quevedo C; Robaeys G; Neri S; Foster GR; Kautz A; Forton D; Pariante CM
    J Hepatol; 2012 Dec; 57(6):1379-90. PubMed ID: 22878466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C and substance use: new treatments and novel approaches.
    North CS; Hong BA; Kerr T
    Curr Opin Psychiatry; 2012 May; 25(3):206-12. PubMed ID: 22395769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
    McGovern B; Fiore J; Wurcel A; Taglienti P; Bradley M; Galvin S; Libone G; Ramsey J; Molinaro-Gudas V; Drewniak S; Amick C; Andalkar A; Scheft H; Bica I
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S56-62. PubMed ID: 16265615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating hepatitis C virus infection in active substance users.
    Sylvestre DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus and depression in drug users.
    Johnson ME; Fisher DG; Fenaughty A; Theno SA
    Am J Gastroenterol; 1998 May; 93(5):785-9. PubMed ID: 9625128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
    Charlebois A; Lee L; Cooper E; Mason K; Powis J
    J Viral Hepat; 2012 Dec; 19(12):836-42. PubMed ID: 23121361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
    Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
    Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
    Huckans MS; Loftis JM; Blackwell AD; Linke A; Hauser P
    Subst Abuse Treat Prev Policy; 2007 Jan; 2():4. PubMed ID: 17222348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hepatitis C].
    Escuret V; Zoulim F
    Rev Prat; 2005 Mar; 55(6):633-45. PubMed ID: 15913115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis.
    Batki SL
    West J Med; 1990 May; 152(5):547-52. PubMed ID: 2190423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.